Table 2.
Clinical data of gastric cancer patient-derived organoids.
| Patient ID | Sex | Age | Diagnosis | TNM (UICC stage) | Tumor differentiation | Histology (Lauren classification) | Tumor site |
|---|---|---|---|---|---|---|---|
| G01 | M | 56 | Adenocarcinoma | T4aN3bM0 (IIIC) | Poor | Diffuse | Antrum |
| G04 | F | 70 | Adenocarcinoma | T4aN3bM0 (IIIC) | Poor | Mixed | Cardia |
| G06a | F | 55 | Adenocarcinoma | T1aN0M0 (IA) | Poor | Diffuse | Body |
| G08 | F | 66 | Adenocarcinoma | T2aN3bM1(IV) | Moderate | Mixed | Body |
| G10 | F | 69 | Adenocarcinoma | T4N3aM0 (IIIA) | Poor | Intestinal | Body |
| G14 | F | 56 | Adenocarcinoma | T4N3aM0 (IIIA) | High | Intestinal | Cardia |
| G16 | F | 69 | Adenocarcinoma | T4aN3aM0 (IIIB) | Moderate | Mixed | Cardia |
| G18 | F | 56 | Adenocarcinoma | T4aN3aM0 (IIIB) | Moderate | Intestinal | Antrum |
| G20a | F | 48 | Adenocarcinoma | T4aN3aM0 (IIIB) | Poor | Diffuse | Body |
| G22a | M | 58 | Adenocarcinoma | T4aN2M0(IIIA) | Poor | Diffuse | Body |
| G23 | M | 47 | Adenocarcinoma | T4aN3aM0 (IIIB) | Poor | Diffuse | Body |
| G25a | F | 55 | Adenocarcinoma | T3NM0(IIA) | Poor | Diffuse | Cardia |
aThe patients (G06, G20, G22, and G25) were diagnosed of SRCC.